ECSP10010597A - Nueva clase de espiro piperidinas para el tratamiento de enfermedades neurodegenerativas - Google Patents

Nueva clase de espiro piperidinas para el tratamiento de enfermedades neurodegenerativas

Info

Publication number
ECSP10010597A
ECSP10010597A EC2010010597A ECSP10010597A ECSP10010597A EC SP10010597 A ECSP10010597 A EC SP10010597A EC 2010010597 A EC2010010597 A EC 2010010597A EC SP10010597 A ECSP10010597 A EC SP10010597A EC SP10010597 A ECSP10010597 A EC SP10010597A
Authority
EC
Ecuador
Prior art keywords
treatment
espiro
piperidines
neurodegenerative diseases
new class
Prior art date
Application number
EC2010010597A
Other languages
English (en)
Spanish (es)
Inventor
Michael Aaron Brodney
Christopher J Helal
Brian Thomas O'neill
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ECSP10010597A publication Critical patent/ECSP10010597A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EC2010010597A 2008-05-05 2010-11-09 Nueva clase de espiro piperidinas para el tratamiento de enfermedades neurodegenerativas ECSP10010597A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5042308P 2008-05-05 2008-05-05

Publications (1)

Publication Number Publication Date
ECSP10010597A true ECSP10010597A (es) 2010-12-30

Family

ID=40902870

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2010010597A ECSP10010597A (es) 2008-05-05 2010-11-09 Nueva clase de espiro piperidinas para el tratamiento de enfermedades neurodegenerativas

Country Status (22)

Country Link
US (1) US20110046160A1 (enExample)
EP (1) EP2300484B1 (enExample)
JP (1) JP2011519913A (enExample)
KR (1) KR20110000749A (enExample)
CN (1) CN102083841A (enExample)
AP (1) AP2010005456A0 (enExample)
AT (1) ATE537178T1 (enExample)
AU (1) AU2009245322B2 (enExample)
BR (1) BRPI0912433A2 (enExample)
CA (1) CA2721786A1 (enExample)
CO (1) CO6321280A2 (enExample)
CR (1) CR11759A (enExample)
DO (1) DOP2010000317A (enExample)
EA (1) EA201001566A1 (enExample)
EC (1) ECSP10010597A (enExample)
ES (1) ES2375913T3 (enExample)
IL (1) IL208793A0 (enExample)
MA (1) MA32290B1 (enExample)
MX (1) MX2010012066A (enExample)
NZ (1) NZ588589A (enExample)
SV (1) SV2010003725A (enExample)
WO (1) WO2009136350A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7763609B2 (en) 2003-12-15 2010-07-27 Schering Corporation Heterocyclic aspartyl protease inhibitors
UA108363C2 (uk) 2009-10-08 2015-04-27 Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування
EP2556076A2 (en) * 2010-04-09 2013-02-13 Pfizer Inc. Novel sultam compounds
WO2012138734A1 (en) 2011-04-07 2012-10-11 Merck Sharp & Dohme Corp. C5-c6 oxacyclic-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
EP2694521B1 (en) 2011-04-07 2015-11-25 Merck Sharp & Dohme Corp. Pyrrolidine-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
RU2014111055A (ru) 2011-08-22 2015-09-27 Мерк Шарп И Доум Корп. 2-спирозамещенные иминотиазины и их моно- и диоксиды в качестве ингибиторов bace, композиции и их применение
EP3233799B1 (en) 2014-12-19 2021-05-19 The Broad Institute, Inc. Dopamine d2 receptor ligands
EP3233077B1 (en) 2014-12-19 2026-05-06 The Broad Institute, Inc. Dopamine d2 receptor ligands

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2359707T3 (es) * 2004-01-08 2011-05-26 F. Hoffmann-La Roche Ag Derivados de diaza-espiropiperidina.
JP2006044497A (ja) * 2004-08-05 2006-02-16 Toyota Motor Corp 車輪情報処理装置
WO2006044497A2 (en) * 2004-10-13 2006-04-27 Merck & Co., Inc. Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzhermer’s disease
CA2615656A1 (en) * 2005-07-18 2007-01-25 Merck & Co., Inc. Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
WO2008030412A2 (en) * 2006-09-07 2008-03-13 Merck & Co., Inc. Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
EP2117309B1 (en) * 2007-01-04 2013-11-06 Merck Sharp & Dohme Corp. Bicyclic spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease

Also Published As

Publication number Publication date
CO6321280A2 (es) 2011-09-20
CA2721786A1 (en) 2009-11-12
IL208793A0 (en) 2010-12-30
MX2010012066A (es) 2010-12-06
CR11759A (es) 2010-11-22
AU2009245322B2 (en) 2011-07-14
AP2010005456A0 (en) 2010-12-31
CN102083841A (zh) 2011-06-01
NZ588589A (en) 2012-07-27
MA32290B1 (fr) 2011-05-02
AU2009245322A1 (en) 2009-11-12
KR20110000749A (ko) 2011-01-05
DOP2010000317A (es) 2010-11-15
BRPI0912433A2 (pt) 2015-12-22
EA201001566A1 (ru) 2011-04-29
WO2009136350A1 (en) 2009-11-12
US20110046160A1 (en) 2011-02-24
EP2300484B1 (en) 2011-12-14
JP2011519913A (ja) 2011-07-14
EP2300484A1 (en) 2011-03-30
ES2375913T3 (es) 2012-03-07
SV2010003725A (es) 2011-07-05
ATE537178T1 (de) 2011-12-15

Similar Documents

Publication Publication Date Title
UY30500A1 (es) Compuestos de azabencimidazolilo
UY31189A1 (es) Compuestos heterocíclicos
UY32977A (es) Novedosos compuestos como inhibidores de la caseina quinasa
CY1118379T1 (el) Αναστολεις ιου ηπατιτιδας c
UY30498A1 (es) Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones
UY33536A (es) INHIBIDORES BICÍCLICOS DE ACETIL-CoA-CARBOXILASA Y USOS DE LOS MISMOS
ECSP11011073A (es) Nuevas lactamas como inhibidores de beta secretasa
UY33921A (es) Oxazinopteridinas y oxazinoptiridinonas n-sustituidas
CL2012001911A1 (es) Compuestos derivados de fumarato; composicion farmaceutica que los comprende; y su uso en el tratamiento de una enfermedad inflamatoria o neurodegenerativa.
CY1118662T1 (el) Νεες δικυκλικες πυριδινονες
CU20110233A7 (es) Sulfonamidas heterocíclicas, usos y composiciones farmacéuticas de las mismas
CU20110207A7 (es) Aril piridinas como inhibidoras de sintasa de aldosterona
ECSP13012611A (es) Derivados de pirazol-aminopirimidina como moduladores de la lrrk2
CR20140399A (es) Pirrolidina-2-carboxamidas sustituidas
UY31127A1 (es) Ligandos de oxiadazol del receptor metabotropico para el glutamato y su utilizacion como potenciadores - 841
CO6491060A2 (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
MX2012004311A (es) Derivados de ciclohexano spiro condensados como inhibidores de lipasa sensible a hormonas (hsl) utiles en el tratamiento de diabetes.
UY31870A (es) Receptor metabotrópico de glutamato potenciadores 286
CO6480932A2 (es) Antagonistas de la trayectoria hedgehog de ftalazina disustituida.
EA201500298A1 (ru) Алкоксипиразолы в качестве активаторов растворимой гуанилатциклазы
CO6321280A2 (es) Nueva clase espiro piperidinas para el tratamiento de enfermedades neurodegenerativas
UY35182A (es) ?COMPUESTOS DE HEXAHIDROPIRANO[ 3,4-d][1,3]TIAZIN-2-AMINA? .
CU20130139A7 (es) Derivados glocósidos y usos de los mismos
UY33348A (es) Compuestos de furopiridina y usos de los mismos
CU20110108A7 (es) [4-(1-amino-etil)-ciclohexil]-metil-aminas como antibacterianos